WithdrawnNCT02811133
Inositol for Comorbid Anxiety in Children and Adolescents With Bipolarity
Medication studyAges 8–17United States
Understand this study
Who could participate?
Listed age limits: 8 years to 17 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: August 2023
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Ronald M. Glick, MD
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 8 Years to 17 Years
- Official registry ID
- NCT02811133
- Official title
Show the full official title
Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Ronald M. Glick, MD.
Does this study involve medication?
Yes. The study involves medication, including Inositol.
Who can participate?
Listed age limits: 8 years to 17 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
